In heart failure-related cardiogenic shock, oliguria-based AKI within 24 hours independently predicted 30-day mortality (adjusted HR 1.92; 95% CI 1.22-3.01), whereas creatinine-based AKI did not.
Cohort (n=394)
Does the presence of oliguria-based or creatinine-based acute kidney injury predict mortality in patients with heart failure-related cardiogenic shock?
In patients with heart failure-related cardiogenic shock, oliguria during the first 24 hours and baseline KDIGO stage V renal dysfunction are strong predictors of 30-day mortality, whereas creatinine-based AKI only predicts longer-term (1-year) mortality.
Hazard Ratio: 1.92 (95% CI 1.22–3.01)
Aims Renal impairment is common in heart failure–related cardiogenic shock (HF-CS), but its prognostic value in earlier stages of HF-CS is unclear. We investigated the prognostic value of renal dysfunction (RD) at HF-CS diagnosis, as well as creatinine- and oliguria-based acute kidney injury (AKI) within the first 24 hours after diagnosis. Methods We studied 394 patients with HF-CS, excluding those with out-of-hospital cardiac arrest or invasive ventilation at diagnosis. RD was staged per KDIGO chronic kidney disease criteria, with AKI crea defined as a creatinine increase ≥26.5 μmol/L (0.3mg/dL) and AKI uo as urine output <0.5 ml/kg/h over 24 hours. The primary outcome was 30-day mortality, while the secondary outcome was 1-year mortality. Results At HF-CS diagnosis, only RD KDIGO stage V was associated with 30-day mortality (adjusted HR, 3.28; 95% CI, 1.66–6.47). AKI crea was not associated with increased 30-day mortality (adjusted HR, 1.05; 95% CI, 0.66–1.66), whereas AKI uo was associated with higher mortality (adjusted HR, 1.92; 95% CI, 1.22–3.01). No interaction was observed between UO and loop diuretic dose for mortality (P = 0.893). At 1 year, both AKI crea (adjusted HR 1.46; 95% CI, 1.05–2.04) and AKI uo (adjusted HR, 1.64; 95% CI, 1.13–2.39) showed a relationship with increased mortality. Conclusions In HF-CS, oliguria during the first 24 hours of CS management was a strong predictor of 30-day mortality, independent of diuretic dose, as was RD stage V. Creatinine-based AKI was not associated with 30-day mortality. Both AKI crea and AKI uo were independent predictors of mortality at 1 year.
Ris et al. (Mon,) conducted a cohort in Heart failure-related cardiogenic shock (n=394). Oliguria-based acute kidney injury (AKI uo) vs. No oliguria-based AKI was evaluated on 30-day mortality (HR 1.92, 95% CI 1.22-3.01). In heart failure-related cardiogenic shock, oliguria-based AKI within 24 hours independently predicted 30-day mortality (adjusted HR 1.92; 95% CI 1.22-3.01), whereas creatinine-based AKI did not.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: